• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普拉梭菌与克罗恩病——二者之间存在关联吗?

Faecalibacterium prausnitzii and Crohn's disease - is there any connection?

机构信息

Institute of Microecology, Poznań, Poland.

出版信息

Pol J Microbiol. 2013;62(1):91-5.

PMID:23829084
Abstract

The aim of the study was evaluation of the correlation between the level of clinical activity of Crohn's disease (CD) and the number of Faecalibacterium prausnitzii, total number of bacteria and the concentration of selected short chain fatty acids (SCFA) in stool. 34 individuals diagnosed with Crohn's disease participated in this study in 2011. The disease activity was determined according to the Crohn Disease Activity Index (CDAI). The number of Faecalibacterium prausnitzii and total number of bacteria were monitored by RT-PCR. The concentrations of SCFA were determined by gas chromatography. In CD patients, Faecalibacterium prausnitzii number and percentage of the total number of bacteria were greatly reduced. In patients with CD the percentage of acetate was elevated (70%), while the percentages of propionate and butyrate were significantly reduced (14.9% and 7.99%, respectively).

摘要

本研究的目的是评估克罗恩病(CD)的临床活动水平与粪便中产双歧杆菌数量、总细菌数量和选定短链脂肪酸(SCFA)浓度之间的相关性。2011 年,34 名确诊为 CD 的患者参与了本研究。疾病活动度根据克罗恩病活动指数(CDAI)进行评估。通过 RT-PCR 监测产双歧杆菌数量和总细菌数量。通过气相色谱法测定 SCFA 浓度。在 CD 患者中,产双歧杆菌数量和总细菌数量的百分比大大减少。在 CD 患者中,乙酸盐的百分比升高(70%),而丙酸盐和丁酸盐的百分比显著降低(分别为 14.9%和 7.99%)。

相似文献

1
Faecalibacterium prausnitzii and Crohn's disease - is there any connection?普拉梭菌与克罗恩病——二者之间存在关联吗?
Pol J Microbiol. 2013;62(1):91-5.
2
Alterations in the relative abundance of correlate with changes in fecal calprotectin in patients with ileal Crohn's disease: a longitudinal study.回肠克罗恩病患者中,[具体内容]相对丰度的改变与粪便钙卫蛋白的变化相关:一项纵向研究。 (你提供的原文中“Alterations in the relative abundance of ”后面缺少具体内容)
Scand J Gastroenterol. 2019 May;54(5):577-585. doi: 10.1080/00365521.2019.1599417. Epub 2019 May 19.
3
Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.肠道微生物群中普拉梭菌丰度降低与克罗恩病有关。
J Gastroenterol Hepatol. 2013 Apr;28(4):613-9. doi: 10.1111/jgh.12073.
4
Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.炎症性肠病和结直肠癌患者肠道黏膜中普拉梭菌菌群I和菌群II丰度的变化
Inflamm Bowel Dis. 2016 Jan;22(1):28-41. doi: 10.1097/MIB.0000000000000590.
5
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.丁酸产生菌罗斯伯里氏菌(Roseburia hominis)和普拉梭菌(Faecalibacterium prausnitzii)的减少定义了溃疡性结肠炎患者的肠道菌群失调。
Gut. 2014 Aug;63(8):1275-83. doi: 10.1136/gutjnl-2013-304833. Epub 2013 Sep 10.
6
Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.与黏膜相关的普拉梭菌和大肠杆菌的共同丰度可区分肠易激综合征和炎症性肠病的表型。
Int J Med Microbiol. 2014 May;304(3-4):464-75. doi: 10.1016/j.ijmm.2014.02.009. Epub 2014 Feb 21.
7
Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?普拉梭菌丰度与克罗恩病有关吗?
FEMS Microbiol Lett. 2010 Sep 1;310(2):138-44. doi: 10.1111/j.1574-6968.2010.02057.x. Epub 2010 Jul 8.
8
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.新发病例小儿炎症性肠病的微生物群:克罗恩病中粪真杆菌增加而细菌多样性减少,但溃疡性结肠炎中则无此变化。
Am J Gastroenterol. 2012 Dec;107(12):1913-22. doi: 10.1038/ajg.2012.335. Epub 2012 Oct 9.
9
Evaluation of Changes in Gut Microbiota in Patients with Crohn's Disease after Anti-Tnfα Treatment: Prospective Multicenter Observational Study.抗 TNF-α 治疗后克罗恩病患者肠道微生物群变化的评估:前瞻性多中心观察性研究。
Int J Environ Res Public Health. 2020 Jul 15;17(14):5120. doi: 10.3390/ijerph17145120.
10
[Specificity comparison of three Feacalibacterium prausnitzii-specific PCR primer pairs].[三种普拉梭菌特异性PCR引物对的特异性比较]
Wei Sheng Wu Xue Bao. 2011 Jun;51(6):819-27.

引用本文的文献

1
Alteration of indicator gut microbiota in patients with chronic sinusitis.慢性鼻窦炎患者肠道指示菌的变化。
Immun Inflamm Dis. 2023 Sep;11(9):e996. doi: 10.1002/iid3.996.
2
Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis.40例埃及复发缓解型多发性硬化症患者的肠道微生物群
Iran J Microbiol. 2021 Oct;13(5):632-641. doi: 10.18502/ijm.v13i5.7428.
3
Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.
共生微生物组在免疫靶向干预期间的免疫调节:关注癌症免疫检查点抑制剂治疗和疫苗接种。
Front Immunol. 2021 May 13;12:643255. doi: 10.3389/fimmu.2021.643255. eCollection 2021.
4
The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.天然抗菌酶溶菌酶在胃肠道炎症条件下上调。
Pathogens. 2014 Jan 16;3(1):73-92. doi: 10.3390/pathogens3010073.
5
Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature.普拉梭菌减少与炎症性肠病之间的关联:一项荟萃分析及文献系统综述
Gastroenterol Res Pract. 2014;2014:872725. doi: 10.1155/2014/872725. Epub 2014 Mar 27.
6
Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.有益肠道共生菌普拉梭菌的生态学与代谢
Gut Microbes. 2014 Mar-Apr;5(2):146-51. doi: 10.4161/gmic.27651. Epub 2014 Jan 22.